Abbott Activated Alanine Aminotransferase Reagent Accuracy Issue Recall
Abbott's A-ALT laboratory reagent may produce inaccurate results in samples with very high enzyme levels or elevated bilirubin, potentially affecting patient diagnoses. The affected product (REF 8L92-21) was distributed worldwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II diagnostic device recall with potential to produce inaccurate test results that could affect clinical decisions. The hazard is theoretical with no reported illnesses, injuries, or hospitalizations, meeting the rubric criterion for High severity as a risk-of-harm medical device where injury has not yet been reported.
Plain-English summary
Abbott Laboratories is recalling its Activated Alanine Aminotransferase (A-ALT) laboratory reagent, REF 8L92-21, for use with the Architect analyzer. The reagent may produce inaccurate results in two specific scenarios: samples with A-ALT values greater than 1,200 U/L may show under-recovery greater than 10%, and samples with bilirubin concentrations greater than 31 mg/dL may show result shifts greater than 10%. These inaccuracies could lead to incorrect patient test results.
The affected reagent was distributed worldwide. In the United States, distribution included California, Idaho, Maine, New York, Pennsylvania, South Dakota, Tennessee, Texas, Utah, and Virginia. The reagent was also distributed internationally to countries including Australia, Austria, Bangladesh, Belgium, Canada, the United Kingdom, China, India, Israel, Mexico, and numerous others. Lot numbers affected are 15014UN20 (expiring 20 October 2021) and 09153UN21 (expiring 9 March 2022).
No illnesses or injuries related to this recall have been reported.
The recalled product
- Product
- REF 8L92-21, Abbott Activated Alanine Aminotransferase, for use with Architect, IVD, CE, UDI: (01) 00380740017866
- Manufacturer
- Abbott Laboratories
- Hazard
- diagnostic-error
- analytical-interference
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03